A Study Evaluating the Effect of Formulation on the Bioavailability of Ipatasertib in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy Volunteer
Interventions
DRUG

ipatasertib (Capsule)

Orally administered single dose of Ipatasertib formulated as a capsule.

DRUG

ipatasertib (Tablet)

Orally administered single dose of Ipatasertib formulated as a tablet.

Trial Locations (1)

53704

Madison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY